SCHEMBL403829

SCHEMBL403829

COCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL92441 0.91
SCHEMBL27036573 0.89 ALDH1A1 (0.32) ALDH1A1
SCHEMBL13621783 0.87
SCHEMBL10301165 0.87
SCHEMBL10005279 0.87
SCHEMBL577857 0.87
SCHEMBL10301172 0.87
SCHEMBL17278402 0.85
SCHEMBL12054089 0.83
SCHEMBL10030942 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210069496-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE INC (US) 2021-03-11 US disclosed
US-10799696-B2 Polymer formulations for nasolacrimal stimulation OCULEVE, INC. (US) 2020-10-13 US disclosed
EP-3689338-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION Oculeve, Inc. (US) 2020-08-05 EP disclosed
EP-3110405-B1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE INC (US) 2020-05-06 EP disclosed
US-20180280688-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE, INC. 2018-10-04 US disclosed
US-9956397-B2 Polymer Formulations for nasolacrimal stimulation OCULEVE, INC. (US) 2018-05-01 US disclosed
US-20170368333-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE, INC. 2017-12-28 US disclosed
US-9770583-B2 Polymer formulations for nasolacrimal stimulation OCULEVE, INC. (US) 2017-09-26 US disclosed
EP-3110405-A2 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION Oculeve, Inc. (US) 2017-01-04 EP disclosed
US-20150376432-A1 INK SET Océ-Technologies B.V. (NL) 2015-12-31 US disclosed
WO-2015130707-A2 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE, INC. (US) 2015-09-03 WO disclosed
US-20150238754-A1 POLYMER FORMULATIONS FOR NASOLACRIMAL STIMULATION OCULEVE, INC. 2015-08-27 US disclosed
US-20140364548-A1 INK COMPOSITION OCE-TECHNOLOGIES B.V. (NL) 2014-12-11 US disclosed
US-8734821-B2 Silicone surfactant-based agricultural formulations and methods for the use thereof OMS INVESTMENTS, INC. (US) 2014-05-27 US disclosed
US-20120061877-A1 Hyrdophilic Surface Modification of Polydimethylsiloxane UTAH STATE UNIVERSITY (US) 2012-03-15 US disclosed